Lazard Asset Management LLC increased its stake in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 54.3% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 27,833 shares of the company's stock after buying an additional 9,800 shares during the quarter. Lazard Asset Management LLC owned 0.30% of Semler Scientific worth $1,502,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. BNP Paribas Financial Markets bought a new stake in Semler Scientific during the 4th quarter valued at $30,000. Jones Financial Companies Lllp purchased a new position in shares of Semler Scientific in the fourth quarter valued at $34,000. Larson Financial Group LLC bought a new stake in shares of Semler Scientific during the 4th quarter valued at $38,000. NewEdge Advisors LLC lifted its holdings in Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock worth $40,000 after purchasing an additional 557 shares in the last quarter. Finally, IFP Advisors Inc purchased a new stake in Semler Scientific during the 4th quarter worth about $54,000. 49.37% of the stock is owned by institutional investors.
Semler Scientific Stock Down 1.4%
Shares of Semler Scientific stock traded down $0.61 on Friday, hitting $44.32. The stock had a trading volume of 1,147,120 shares, compared to its average volume of 493,030. The stock's 50-day simple moving average is $35.99 and its two-hundred day simple moving average is $47.15. Semler Scientific, Inc. has a one year low of $21.77 and a one year high of $81.56. The stock has a market cap of $494.26 million, a price-to-earnings ratio of 9.03 and a beta of 1.33.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The business had revenue of $8.84 million for the quarter.
Analyst Ratings Changes
A number of analysts recently weighed in on SMLR shares. Lake Street Capital boosted their target price on Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Wall Street Zen lowered Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday.
Get Our Latest Report on SMLR
Semler Scientific Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
See Also
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
